Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
06/2008
06/12/2008WO2008069322A1 Metal coordination compound and light-emitting material using the same
06/12/2008WO2008069242A1 Novel bicyclic heterocyclic compound
06/12/2008US20080139813 Reacting perylene-3,4,9,10-tetracarboxylic acid, a 1,4,5,8-naphthalene-tetracarboxylic acid, or anhydrides, imides, an amine, and a solvent, in the presence of an oxidation/reduction catalyst
06/12/2008US20080139616 Atherosclerosis; inflammatory diseases, Alzheimer's disease, dyslipidemia, metabolic syndrome; 2-isopropyl-5-phenyl-4-[(4-phenylbutyl)amino]isothiazole-3(2H)-thione 1,1-dioxide for example
06/12/2008US20080139585 phenyl-, pyridyl-, pyrimidyl- and purine- derivatives; anticarcinogenic agent; solid tumor: breast, colorectal, lung, prostate, and ovarian
06/12/2008US20080139556 1-(3-Trifluoromethyl-benzenesulfonyl)-piperidine-2-carboxylic acid [(S)-1-(4-dimethylamino-phenylcarbamoyl)-2-(4-methoxy-phenyl)-ethyl]-amide;FK-binding protein/immunophilins modulator; neurodegenerative diseases; Parkinson's disease, multiple sclerosis, Alzheimer's disease, stroke, spinal cord injury
06/12/2008US20080139538 Tertiary Carbinamines Having Substituted Heterocycles Which Are Active As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease
06/12/2008US20080139461 Containing the sequence RGD for the preparation of appropriately functionalised antagonists of alpha v beta 3 and alpha v beta 5 integrins; treatment of altered angiogenic phenomena or for the preparation of diagnostically useful compounds
06/12/2008US20080138651 Polyanilines; strong fluorescence and large charge transporting properties
06/12/2008US20080138375 Macrocyclic lactone compounds and methods for their use
06/12/2008US20080138287 3-substituted-2(arylalkyl)-1- azabicycloalkanes and methods of use thereof
06/12/2008DE102006057612A1 New spiro compounds useful as photo-adjustable catalysts in organic synthesis and as photo-catalysts in the polymerization reaction
06/11/2008CN100393704C Novel alkali B of cohosh root and its uses in preparing anti-myocardial ischemia drug
06/10/2008US7384954 3-Imidazol-1-yl-1-azabicyclo[2.2.2]octane; agonist, partial agonist, or antagonist of the alpha 7 nicotinic acetylcholine receptor; antidepressant, anxiolytic agent, cognition activator, neuroprotectant; radiolabel
06/10/2008US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof
06/05/2008WO2008066024A1 Anthrapyridone compound, salt thereof, magenta ink composition and colored body
06/05/2008WO2008005295A3 Modulators of muscarinic receptors
06/05/2008US20080132600 Safe toxicity, fire, storage and explosive profile; free radical polymerization; such as n-imidoester derivatives; infrared, ultraviolet, microwave, convection and/or ultrasound curable coatings
06/05/2008US20080132544 Peroxisome Proliferator-Activated Receptor Ligand
06/05/2008US20080132485 Amide substituted heterocylic compound; anticarcinogen; inducing apoptotic cell death, sensitizing cells to inducers of apoptosis
06/04/2008EP1927595A2 Salts of clopidogrel and process for preparation
06/04/2008EP1729723B1 Neutral and cationic naphthalene derivatives and dyes containing said compounds for dyeing keratin fibers
06/04/2008CN100391960C Chemical semi-synthetic process for high-purity 10-hydroxy-camptothecin
06/04/2008CN100391958C Chemical compounds
06/03/2008US7381823 Condensing cyclohexanone with cyanoacetamide and reacting 2-cyclohexylidene-2-cyanoacetamide formed with malonate to form 3-cyano-5-carboxy-2,4-dioxo-3-azaspiro[5,5]undecane (claimed as an intermediate); hydrolysis, decarboxylation and further hydrolysis to form 3,3-pentamethyleneglutaramic acid
05/2008
05/29/2008US20080125429 1-{[5-[4-(Methylsulfonyl)phenoxy]-2-(2-pyridinyl)-1H-benzimidazol-6-yl]methyl}-5-thioxo-2-pyrrolidinone;glucokinase activator; antidiabetic agents; obesity; prevention of retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis; antiischemic agents; cardiotonic agents
05/29/2008US20080125424 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
05/29/2008US20080125399 N-[3-(trifluoromethyl)pyridin-2-yl]-4-methyl-6-methyl-3-oxo-4-aza-5 alpha -androst-5-en-17 beta -acetamide; useful for the treatment of conditions caused by androgen deficiency such as osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, cancer cachexia, Alzheimer's disease
05/29/2008US20080122428 Optimized Determination of Voltage Changes Using a Voltage-Sensitive Dye
05/28/2008EP1924559A2 8-carboxamido-substituted-2 , 6-methano-3-benzazocines and 3 - carboxamido- substituted morphanes as opioid receptor binding agents
05/28/2008EP1556382B1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof
05/28/2008EP1496898B1 Tyrosine kinase inhibitors
05/28/2008CN100390177C Preparation method of 6-cyano-7-methyl-1,1-(2,2-dimethyl-1,3-propylidine dioxy)-5-oxo-1,2,3,5-tetrahydro indolidin (I)
05/28/2008CN100390172C Methane sulfonic acid dolasetron crystallographic form and its preparation method
05/28/2008CN100390146C Process for making risperidone and intermediates therefor
05/27/2008US7378524 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors.
05/27/2008US7378427 Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines
05/22/2008WO2008059513A2 Compounds suitable as modulators of hdl
05/22/2008WO2008058342A1 Compounds, compositions and methods for controlling invertebrate pests
05/22/2008US20080119505 (4aR,10bR)-6-(2,6-Dimethoxy-pyridin-3-yl)-8,9-dimethoxy-1,2,3,4,4a,10b-hexahydro-phenanthridine; phosphodiesterase inhibitor; airway obstructions, antiinflammatory agent, antidepressant; dermatoses, eczema, lupus, rheumatoid arthritis, osteoarthritis, AIDS, multiple sclerosis, graft versus host reaction
05/22/2008US20080119504 aporphine 10- and 11-mono-esters and 10,11-asymmetric di-esters; dopaminergic agonist; Parkinson's disease, hemicrania, restless leg syndrome, sexual dysfunction, hyperprolactemia and psychotic disorders
05/22/2008US20080119503 Androgen receptor modulators and methods of use thereof
05/22/2008CA2670259A1 Compounds, compositions and methods for controlling invertebrate pests
05/21/2008EP1923387A1 Acylguanidine derivative or salt thereof
05/21/2008EP1923386A2 Carbamate caspase inhibitors and uses thereof
05/21/2008EP1922381A1 Printable materials
05/21/2008EP1599206A4 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
05/21/2008CN101184759A Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
05/20/2008US7375225 4-cyanocoumarin derivatives and uses thereof
05/15/2008WO2008056059A2 4-azasterol derivatives, methods for the synthesis thereof and use of same as drugs
05/15/2008WO2008008310A3 Tyrosine kinase inhibitors
05/15/2008US20080114170 Method For Producing Perylene-3,4-Dicarboxylic Acid Imides
05/14/2008EP1919873A1 Fredericamycin derivatives
05/14/2008EP1919867A2 Lisofylline analogues and their pharmeacuetical uses
05/14/2008EP1660184A4 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
05/14/2008CN101180057A Piperidinyl substituted cyclohexane-1,4-diamines
05/14/2008CN100387598C Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
05/14/2008CN100387597C Amide substituted imidazopyridines
05/08/2008WO2008052927A1 Heptarylene and octarylene tetracarboxylic acid diimides, and production thereof
05/08/2008WO2007136607A3 Substituted esters as cannabinoid-1 receptor modulators
05/08/2008US20080108647 Treatment of HIV and diseases of immune dysregulation
05/08/2008CA2667826A1 Inhibitors of histone deacetylase
05/07/2008EP1918272A1 Pharmaceutically active compounds and methods of use
05/07/2008EP1917311A2 Multiple chromophores
05/07/2008EP1250325B1 Phenanthridine-n-oxides
05/07/2008CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
05/06/2008US7368457 Bridged N-arylsulfonylpiperidines as gamma-secretase inhibitors
05/01/2008US20080103139 3-Carbamoyl-2-Pyridone Derivative
05/01/2008US20080102402 Monomer having sulfonyl group, polymer thereof and photoresist composition including the same
04/2008
04/30/2008EP1915386A1 Metal complex
04/30/2008CN101171222A Terrylene and quaterrylene derivatives
04/30/2008CN100384837C Novel farnesyl protein transferase inhibitors as antitumor
04/30/2008CN100384418C Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
04/29/2008US7365202 Polymorphs of an androgen receptor modulator
04/29/2008US7365197 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
04/29/2008US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders
04/24/2008US20080097122 Synthesis of 1,1-cyclohexane acetic acid monoamide, an intermediate used in the preparation of gabapentin, by hydrolysis reaction of alpha ,--diaminocarbonyl- beta , beta -pentamethylene glutarimide
04/24/2008US20080097100 Opiate Intermediates and Methods of Synthesis
04/24/2008US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/23/2008EP1476141B1 Tamper-resistant transdermal opioid delivery devices
04/23/2008EP1333834B1 Antiinflammation agents
04/23/2008EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2008CN100383126C Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
04/22/2008US7361762 Process for preparing acid salts of Gemifloxacin
04/22/2008US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group
04/17/2008WO2008044702A1 Process for production of azabicycloalkanol derivative
04/17/2008WO2008044701A1 Method for producing piperidin-4-one derivative
04/17/2008US20080090865 Non-insulin dependent diabetes; agonists of G-protein coupled receptor 40 (GPR40); for example, 3-(indan-1-yloxy)-8-(oxazolidin-2,4-dion-5-yl)-5,6,7,8-tetrahydroquinoline
04/17/2008US20080090830 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer
04/17/2008US20080090794 Potassium Channel Inhibitors
04/16/2008CN101161641A Tricyclic steroid hormone nuclear receptor modulators
04/15/2008USRE40245 Gyrase inhibitors and uses thereof
04/15/2008US7358362 Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis
04/15/2008US7358244 Azabicycloalkane compounds
04/10/2008WO2007019180A3 Compounds for binding to eralpha/beta and gpr30, methods of treating disease states and conditions mediated through these receptors and identification thereof
04/10/2008US20080085884 Eating disorders, psychological disorders, sexual disorders, nervous system disorders, sleep disorders, autism; 4-(Benzyloxy)-6'-[3-methyl-3-(methylamino)pyrrolidin-1-yl]-2H-1,3'-bipyridin-2-one for example
04/10/2008US20080085469 Novel photoacid generators, resist compositions, and patterning process
04/09/2008EP1908752A1 Novel 2-quinolone derivative
04/09/2008EP1907390A2 Diazepinoquinolines, synthesis thereof, and intermediates thereto
04/09/2008CN100379735C 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 110